284 related articles for article (PubMed ID: 8280772)
1. Comparison of 1-O-alkyl-, 1-O-alk-1'-enyl-, and 1-O-acyl-2-acetyl-sn-glycero-3-phosphoethanolamines and -3-phosphocholines as agonists of the platelet-activating factor family.
O'Flaherty JT; Tessner T; Greene D; Redman JR; Wykle RL
Biochim Biophys Acta; 1994 Jan; 1210(2):209-16. PubMed ID: 8280772
[TBL] [Abstract][Full Text] [Related]
2. Differential responsiveness of human neutrophils to the autocrine actions of 1-O-alkyl-homologs and 1-acyl analogs of platelet-activating factor.
Pinckard RN; Showell HJ; Castillo R; Lear C; Breslow R; McManus LM; Woodard DS; Ludwig JC
J Immunol; 1992 Jun; 148(11):3528-35. PubMed ID: 1316919
[TBL] [Abstract][Full Text] [Related]
3. 1-O-hexadec-1'-enyl-2-acetyl-sn-glycero-3-phosphocholine and its biological activity.
Nakayama R; Yasuda K; Satouchi K; Saito K
Biochem Biophys Res Commun; 1988 Mar; 151(3):1256-61. PubMed ID: 3355555
[TBL] [Abstract][Full Text] [Related]
4. The CoA-independent transacylase in PAF biosynthesis: tissue distribution and molecular species selectivity.
Blank ML; Smith ZL; Fitzgerald V; Snyder F
Biochim Biophys Acta; 1995 Feb; 1254(3):295-301. PubMed ID: 7857969
[TBL] [Abstract][Full Text] [Related]
5. A novel CoA-independent transacetylase produces the ethanolamine plasmalogen and acyl analogs of platelet-activating factor (PAF) with PAF as the acetate donor in HL-60 cells.
Lee TC; Uemura Y; Snyder F
J Biol Chem; 1992 Oct; 267(28):19992-20001. PubMed ID: 1400315
[TBL] [Abstract][Full Text] [Related]
6. Metabolic fate of platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) in FRTL5 cells.
Botitsi E; Mavri-Vavayanni M; Siafaka-Kapadai A
J Lipid Res; 1998 Jun; 39(6):1295-304. PubMed ID: 9643362
[TBL] [Abstract][Full Text] [Related]
7. [Acyl and plasmalogen analogs of platelet activating factor--new lipid cellular bioregulators].
Kulikov VI; Muzia GI
Biokhimiia; 1992 Jun; 57(6):803-16. PubMed ID: 1420585
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of platelet-activating factor by arachidonic acid-depleted rat polymorphonuclear leukocytes.
Ramesha CS; Pickett WC
J Biol Chem; 1986 Nov; 261(33):15519-23. PubMed ID: 3096991
[TBL] [Abstract][Full Text] [Related]
9. Biological effects of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in the human neutrophil.
Triggiani M; Goldman DW; Chilton FH
Biochim Biophys Acta; 1991 Jun; 1084(1):41-7. PubMed ID: 1647203
[TBL] [Abstract][Full Text] [Related]
10. Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor.
Smiley PL; Stremler KE; Prescott SM; Zimmerman GA; McIntyre TM
J Biol Chem; 1991 Jun; 266(17):11104-10. PubMed ID: 1645725
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells.
Blank ML; Spector AA; Kaduce TL; Lee TC; Snyder F
Biochim Biophys Acta; 1986 May; 876(3):373-8. PubMed ID: 3707974
[TBL] [Abstract][Full Text] [Related]
12. Evidence that hydrolysis of ethanolamine plasmalogens triggers synthesis of platelet-activating factor via a transacylation reaction.
Nieto ML; Venable ME; Bauldry SA; Greene DG; Kennedy M; Bass DA; Wykle RL
J Biol Chem; 1991 Oct; 266(28):18699-706. PubMed ID: 1917994
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of platelet activating factor and metabolism of related lipids in embryonic cells.
Chepenik KP; Wykle RL
Biochim Biophys Acta; 1992 Jun; 1126(2):192-8. PubMed ID: 1627622
[TBL] [Abstract][Full Text] [Related]
14. Differential actions of diacyl- and alkylacylglycerols in priming phospholipase A2, 5-lipoxygenase and acetyltransferase activation in human neutrophils.
Bauldry SA; Wykle RL; Bass DA
Biochim Biophys Acta; 1991 Jul; 1084(2):178-84. PubMed ID: 1854803
[TBL] [Abstract][Full Text] [Related]
15. Ether phospholipids as inhibitors of the arachidonoyl-CoA: 1-acyl-sn-glycero-3-phosphocholine acyltransferase in macrophages.
Herrmann DB; Ferber E; Munder PG
Biochim Biophys Acta; 1986 Mar; 876(1):28-35. PubMed ID: 3947667
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by cultured rat Kupffer cells.
Chao W; Siafaka-Kapadai A; Hanahan DJ; Olson MS
Biochem J; 1989 Jul; 261(1):77-81. PubMed ID: 2775221
[TBL] [Abstract][Full Text] [Related]
17. Influence of platelet-activating factor, its cell analogs, and antagonist on the production of superoxide radicals by blood leukocytes of healthy and hypercholesterolemic individuals.
Kulikov VI; Muzya GI
Biochemistry (Mosc); 2002 Jun; 67(6):662-6. PubMed ID: 12126473
[TBL] [Abstract][Full Text] [Related]
18. Tea polyphenols inhibit acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine acetyltransferase (a key enzyme in platelet-activating factor biosynthesis) and platelet-activating factor-induced platelet aggregation.
Sugatani J; Fukazawa N; Ujihara K; Yoshinari K; Abe I; Noguchi H; Miwa M
Int Arch Allergy Immunol; 2004 May; 134(1):17-28. PubMed ID: 15051936
[TBL] [Abstract][Full Text] [Related]
19. Stimulation and priming of protein kinase C translocation by a Ca2+ transient-independent mechanism. Studies in human neutrophils challenged with platelet-activating factor and other receptor agonists.
O'Flaherty JT; Redman JF; Jacobson DP; Rossi AG
J Biol Chem; 1990 Dec; 265(35):21619-23. PubMed ID: 2174881
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human platelet aggregation by amides and ester of salicylic acid with platelet-activating factor analogs.
Kulikov VI; Muzya GI
Biochemistry (Mosc); 2001 Jun; 66(6):658-61. PubMed ID: 11421815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]